BioCatalyst

Ritlecitinib 100 mg, Ritlecitinib 50 mg — catalyst calendar

1 verified catalyst event(s) referencing Ritlecitinib 100 mg, Ritlecitinib 50 mg, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-21
in 5mo
ESTIMATED
 READOUT
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alop
Phase 3 · Alopecia Areata
 PFE PFIZER INC Ritlecitinib 100 mg, Ritlecitinib 50 mg ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.